Back to results
RecruitingPhase 1Phase 2

Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors

NCT07523529

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Peking University Shenzhen Hospital

Shenzhen, Guangdong, China

View on ClinicalTrials.gov
Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors — TrialFind